Mosul University
  • Register
  • Login
  • العربیة

Iraqi Journal of Pharmacy

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 19, Issue 2
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Peer Review Process

News

Guide to reviwers

Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff

    Wail M. Sadeq Eanas I. Khalid Waleed H. Khudhur

Iraqi Journal of Pharmacy, 2022, Volume 19, Issue 2, Pages 63-73
10.33899/iphr.2022.176652

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: A key public health intervention strategy to stop the spread of infectious diseases, such as the present COVID-19 pandemic, is vaccination.  Nearly 190 COVID-19 vaccines are now being developed at various phases of pre-clinical and clinical testing, with a few vaccines recently receiving Emergency Use Authorizations (EUA) and being accepted by the WHO in several regions of the world.
Patients and Methods: A cross-sectional design was adopted to conduct the study which involve all medical staff who attends to Covid-19 vaccination center at Al-Mosul General Hospital during the period from 1st July 2021 to 31st November 2021. The study sample was 200 participants of different specializations who attend to take the 1st or the 2nd dose of the Covid-19 vaccine. The interview was done by the researchers directly through a checklist. The statistical analysis was done with IBM-SPSS-26.  
Results: The mean age of the study sample is 34.8 years, 56.5% of them are males and 43.5% are females, fever is the most frequent side effect representing 49.0%, and the inflammatory reaction at the site of injection whether mild or severe represents 35.0%, pain at the injection site occurs in 28.5%, and headache occurs in 9.5%, shows that 69.7% are females and 30.3% are males. The Pfizer vaccine of batch no. FJ8198, FM3444, and FJ1966 were associated with side effects more than others.
Conclusion: COVID-19 vaccine showed that the safety of the vaccine with no major side effects emerging and females were more prone to experience side effects. The Pfizer vaccine of batch no. FJ8198, FM3444, and FJ1966 were associated with side effects more than others.
Keywords:
    COVID-19 Iraqi Medical staff Pfizer-BioNTech vaccine Side effects
  • PDF (1384 K)
  • XML
(2022). Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff. Iraqi Journal of Pharmacy, 19(2), 63-73. doi: 10.33899/iphr.2022.176652
Wail M. Sadeq; Eanas I. Khalid; Waleed H. Khudhur. "Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff". Iraqi Journal of Pharmacy, 19, 2, 2022, 63-73. doi: 10.33899/iphr.2022.176652
(2022). 'Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff', Iraqi Journal of Pharmacy, 19(2), pp. 63-73. doi: 10.33899/iphr.2022.176652
Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff. Iraqi Journal of Pharmacy, 2022; 19(2): 63-73. doi: 10.33899/iphr.2022.176652
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 61
  • PDF Download: 50
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus